H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy on ACHV; target 12 vs price 6.77
Target: $12
Posted price: $6.77
Analyst firm: H.C. Wainwright
Analyst: Brandon Folkes
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.